Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

33012-73-6

Cyanidin 3-sambubioside chloride

33012-73-6
07/09/3650

Carnosic acid

07/09/3650
37148-27-9

Clenbuterol

37148-27-9
877399-52-5

Crizotinib

877399-52-5
1032900-25-6

Ceritinib

1032900-25-6
38339-18-3

Hydroxymethylclenbuterol HCl

38339-18-3
528851-31-2

Desethylene Ciprofloxacin HCl

528851-31-2
72956-09-3

Carvedilol

72956-09-3
50370-12-2

Cefadroxil

50370-12-2
10206-21-0

Cefacetrile / Cephacetrile

10206-21-0
70356-03-5

Cefaclor H2O

70356-03-5
2016-36-6

Choline Salicylate

2016-36-6
1391054-00-4

Hydroxy Chlorodenafil

1391054-00-4
115-93-5

Cythioate

115-93-5
113-92-8

Chlorpheniramine Maleate

113-92-8
79350-37-1

Cefixime

79350-37-1
NA

24-Methylene cholesterol

NA
38821-49-7

Carbidopa Monohydrate

38821-49-7
64485-93-4

Cefotaxime sodium

64485-93-4
87239-81-4

Cefpodoxime proxetil

87239-81-4